BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Kythera Biopharmaceuticals Announces Positive ATX-101 Top Line Phase 3 Trial Results for the Reduction of Submental Fat

  September 17, 2013

   · 

  1 min read
• Drug Development

  Repros Therapeutics Inc. Reports Preliminary Findings: Second Pivotal Study and 6-Month Safety Study Support Androxal® Approvability

  September 17, 2013

   · 

  1 min read
• BioMidwest

  Vascular Solutions Surpasses 30,000 Successfully Reprocessed ClosureFAST® Catheters

  September 17, 2013

   · 

  1 min read
• Business

  Nuvilex Contracts With Inno Biologics, an FDA-Compliant Provider, for Initial Generation of Cloned Cells for Future Phase 3 Clinical Trials

  September 17, 2013

   · 

  1 min read
• Biotech Bay

  BioMarin Pharmaceutical Inc. Provides Highlights Ahead of Research and Development Day

  September 17, 2013

   · 

  1 min read
• Pharm Country

  Celsus Therapeutics Announces ADR Ticker Symbol Change to CLSXY

  September 17, 2013

   · 

  1 min read
• Biotech Bay

  Applied Biomics, Inc. Launches Host Cell Protein Assays Using 2D DIGE Western Blot

  September 17, 2013

   · 

  1 min read
• Drug Development

  Compugen Ltd. Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types Involved in Tumor Progression

  September 17, 2013

   · 

  1 min read
• BioMidwest

  MBio Diagnostics, Inc. Announces Expansion of Patent Portfolio

  September 17, 2013

   · 

  2 min read
• Business

  Heliae and Triton Partner to Bring Algae Therapeutics to Market

  September 17, 2013

   · 

  4 min read